Aptevo Therapeutics Inc. APVO
1.35 USD +0.01 +0.75%
At close · Nov 2
1.34 -0.01 -0.74%
After hours · Nov 2, 4:00 PM ET
- YTD
- -85.68%
- 1 year
- -95.16%
- Open
- 1.39
- Prev close
- 1.34
- Mkt cap
- 2.44M
- Vol
- 22.79K
- Avg vol
- 96.57K
- EPS
- 68.96
- P/E
- 0.02
- Div yield
- 0.00%
More statistics
- Low
- 1.35
- High
- 1.40
- Forward P/E
- -0.83
- Beta
- 5.07
- Short ratio
- 0.47
- Inst. own
- 11.36%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 4, 2024
- 50-d avg
- 8.69
- 200-d avg
- 31.59
- 1y target
- 21.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for APVO has not been loaded yet. Try again in a moment.
Altman Z-Score
-33.17 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
P/E -0.1×
P/S 0.0×
P/B 0.0×
P/FCF -0.0×
EV/EBITDA 0.7×
EV/Sales 0.0×
FCF Yield -86018.8%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -149.4%
ROIC -119.5%
ROA -95.5%
Revenue 0.0%
Operating Income -7.0%
EPS (diluted) 99.7%
Free Cash Flow -7.6%
Current Ratio 3.8×
Quick Ratio 3.8×
Debt / Equity 0.3×
Net Debt / EBITDA 0.7×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31